We engineer the microbiome with unprecedented precision to prevent, treat or cure microbiome-associated diseases. Join us!
Location: France, Ile-de-France, Paris
Total raised: $30M
Investors 2
| Date | Name | Website |
| - | Agoranov | agoranov.c... |
| - | CARB-X | carb-x.org |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 05.12.2023 | Series B | $30M | - |
Mentions in press and media 4
| Date | Title | Description | Source |
| 05.12.2023 | Eligo Bioscience Raises $30M in Series B Funding | Eligo Bioscience, a Paris, France-based gene-editing company, raised $30M in Series B funding. The ... | finsmes.co... |
| 15.06.2022 | After 3 years away, BIO marked by first-time handshakes and ... | Six days after the World Health Organization officially declared COVID-19 a global pandemic on March... | fiercebiot... |
| 11.01.2021 | Could Crispr Eradicate Acne? | Eligo Bioscience's management team from left: CEO Xavier Duportet, PhD, Chief Business Officer, ... ... | forbes.com... |
| - | Eligo Bioscience | “Eligo Bioscience is deploying in vivo gene editing technologies against microbiome targets to addre... | fastfounde... |